A PYMNTS Company

US: Chinese vitamin firm fights $153M price-fixing fine

By  |  December 5, 2013

A Chinese vitamin producer announced Thursday it is planning on filing an appeal of an earlier US decision that found the company, along with three others, of conspiring to fix vitamin prices in the US.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    NCPC’s appeal will be the first time a Chinese pharmaceutical firm has been fined by US regulators in an antitrust case, say reports.

    The US District Court for the Eastern District of New York offered the ruling November 26, ordering the Chinese firm to pay $153.3 million for the Vitamin C collusion.

    Full Content: CRJEnglish

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.